Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT02036658 Completed - Clinical trials for Social Anxiety Disorder

Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder

Start date: March 2011
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the immediate and longer-term impact of Cognitive-Behavioral Group Therapy (CBGT) versus Mindfulness-Based Stress Reduction (MBSR) for patients with Social Anxiety Disorder.

NCT ID: NCT02033382 Completed - Schizophrenia Clinical Trials

Biomarkers in First Episode Schizophrenia

Start date: July 2012
Phase:
Study type: Observational

This study will identify and evaluate relevant biomarkers and structural brain imaging for understanding potential biological illness related mechanisms in medication-naïve subjects with early psychosis before and after initiation of antipsychotic medication

NCT ID: NCT02033161 Completed - Clinical trials for Irritable Bowel Syndrome

Internet-delivered Cognitive Behavior Therapy for Adolescents With Functional Gastrointestinal Disorders: a Pilot Study

Start date: March 2012
Phase: N/A
Study type: Interventional

This pilot-study aims to evaluate the treatment effects and feasibility of an internet-delivered CBT-program for adolescents with functional gastrointestinal disorders.

NCT ID: NCT02032680 Completed - Schizophrenia Clinical Trials

Comparison of E-health vs. In-person Multi-Family Group (MFG)

Start date: August 19, 2015
Phase: N/A
Study type: Interventional

As specified in the VA Uniform Services Handbook, Family Psycho-Education (FPE) treatment must be available to all Veterans with schizophrenia who could benefit, and their family members. This includes those receiving care at Community Based Outpatient Clinics (CBOCs), and at Psychosocial Rehabilitation and Recovery Centers (PRRCs), whether provided on site, by referral, or by telemental health. However, less than 5% of VA medical centers offer FPE. Clearly, a major challenge is to devise ways to deliver mental health treatments and services to Veterans who need them in ways that meet their needs and preferences. The proposed project will compare the use of a website to deliver FPE to that of in-person delivered FPE. The findings could have profound implications for the VA's ability to improve the reach, use, appeal, and effectiveness of FPE for Veterans with schizophrenia, by using an e-health model that facilitates family involvement.

NCT ID: NCT02030288 Completed - Clinical trials for Alcohol Use Disorder

Relational Agent for Alcohol Screening and Treatment

RAAST
Start date: February 19, 2015
Phase: N/A
Study type: Interventional

This project will involve the development and initial evaluation of a promising computer-based intervention to improve the primary care management of risky alcohol use among Veterans. The intervention uses a Relational Agent, an on-screen "person" that establishes a relationship with the Veteran to promote positive health behaviors. This study will determine how Veterans interact with this system, how it can be tailored to Veterans' preferences, and its potential effect on risky drinking. If ultimately proven effective, the Relational Agent will have several impacts on Veterans and their health care, including: - (1) lower rates of risky drinking in Veterans - (2) improved rates of brief counseling for Veterans with excessive alcohol use - (3) increased proportion of Veterans referred to Mental Health for alcohol disorders - (4) improved care for Veterans with low levels of health literacy. This study directly supports Secretary Shinseki's Transformational Initiative to employ state-of-the-art information technology to improve quality and access of Veterans' health care.

NCT ID: NCT02028533 Completed - Opioid Use Disorder Clinical Trials

Cocaine Opioid Oxytocin Option - Limited

COOOL
Start date: July 2014
Phase: Phase 1
Study type: Interventional

This is a pilot feasibility study assessing the tolerability of chronic administration of intranasal oxytocin to patients receiving methadone at an opioid replacement clinic who are actively using cocaine.

NCT ID: NCT02028247 Completed - Autism Clinical Trials

Psychotherapy for Anxiety in Children With Autism Spectrum Disorder

TAASD
Start date: April 2014
Phase: N/A
Study type: Interventional

Anxiety disorders affect 40 to 50% of children with autism spectrum disorders (ASD), contributing to substantial distress and impairment. The goal of this study is to examine the effectiveness of a personalized type of psychotherapy against standard-care psychotherapy for addressing anxiety in youth with ASD.

NCT ID: NCT02022709 Completed - Anxiety Disorders Clinical Trials

Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients

Start date: January 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficiency of SSRIs(Selective Serotonin Reuptake Inhibitor) ,ERP(Exposure and Response Prevention) and the combination of the two therapies for OCD(Obsessive-Compulsive Disorder) patients ,at the same time, to find out the biological or psychological predictors of treatment response in Chinese population.

NCT ID: NCT02013531 Completed - Anxiety Clinical Trials

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Start date: November 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of flexibly dosed adjunctive brexpiprazole treatment in subjects with major depressive disorder and anxiety symptoms, who are experiencing an inadequate selective serotonin reuptake inhibitor (SSRI)/serotonin norepinephrine reuptake inhibitor (SNRI) response.

NCT ID: NCT02010619 Completed - Clinical trials for Body Dysmorphic Disorder

Internet Delivered CBT for Body Dysmorphic Disorder

Start date: November 2013
Phase: N/A
Study type: Interventional

To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment when compared to a control group consisting of supportive therapy.